| Followers | 934 |
| Posts | 159778 |
| Boards Moderated | 2 |
| Alias Born | 08/13/2010 |
Thursday, May 15, 2025 1:14:54 AM
$DAREFull article in comments.
— Dr. Kat Lindley (@DrKatLindley) May 13, 2025
“COVID-19 vaccines decreased the number of primordial follicles “the foundation of fertility” in female rats by up to 60%, according to a peer-reviewed study published in Vaccines. The authors said their results justify “further investigations into the… pic.twitter.com/VkPCG36wpP
Bearish
Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.
Recent DARE News
- Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer • GlobeNewswire Inc. • 05/26/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/18/2026 08:25:47 PM
- Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies • GlobeNewswire Inc. • 05/18/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:03:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:01:25 PM
- Daré Bioscience Reports First Quarter 2026 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/14/2026 08:01:00 PM
- Positive Interim Phase 3 Results Highlight Potential of Ovaprene®, Novel Hormone-Free Contraceptive • GlobeNewswire Inc. • 05/12/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:11:05 PM
- Daré Bioscience to Host First Quarter 2026 Financial Results and Company Update Conference Call and Webcast on May 14, 2026 • GlobeNewswire Inc. • 05/07/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:40:46 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 08:33:21 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:02:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 01:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/20/2026 08:07:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2026 08:10:22 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/17/2026 08:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 08:58:43 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 04/02/2026 04:15:02 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 08:02:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:01:23 PM
- Daré Bioscience Reports Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/26/2026 08:01:00 PM
- On National Viagra Day, Women Finally Claim Their Turn: • GlobeNewswire Inc. • 03/23/2026 12:00:00 PM
- Daré Bioscience to Host Full Year 2025 Financial Results and Company Update Conference Call and Webcast on March 26, 2026 • GlobeNewswire Inc. • 03/20/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 08:37:30 PM
- Dare Bioscience secures NIH funding extension for preterm birth therapy • IH Market News • 03/16/2026 02:29:18 PM
